| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014
|
Sarin, Shiv Kumar
|
|
2014
|
8 |
4 |
p. 453-471
|
artikel
|
| 2 |
Assessment of diastolic function in the management of patients with cirrhosis
|
Møller, Søren
|
|
2014
|
8 |
4 |
p. 472-474
|
artikel
|
| 3 |
Assessment of the features of serum apolipoprotein profiles in chronic HCV infection: difference between HCV genotypes 1b and 2
|
Seki, Nobuyoshi
|
|
2014
|
8 |
4 |
p. 550-559
|
artikel
|
| 4 |
Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae: a retrospective cohort study
|
Kim, Min Jae
|
|
2014
|
8 |
4 |
p. 582-587
|
artikel
|
| 5 |
Community-based hepatitis B screening: what works?
|
Robotin, Monica C.
|
|
2014
|
8 |
4 |
p. 478-492
|
artikel
|
| 6 |
Diagnostic role of radiolabelled choline PET or PET/CT in hepatocellular carcinoma: a systematic review and meta-analysis
|
Bertagna, Francesco
|
|
2014
|
8 |
4 |
p. 493-500
|
artikel
|
| 7 |
Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis
|
Karagiannakis, Dimitrios S.
|
|
2014
|
8 |
4 |
p. 588-594
|
artikel
|
| 8 |
Erratum to: Yttrium-90 radioembolization for hepatocellular carcinoma in hepatitis B: commentary on a 103-patient Asian cohort
|
Kulik, Laura
|
|
2014
|
8 |
4 |
p. 595
|
artikel
|
| 9 |
Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial
|
Shiffman, Mitchell L.
|
|
2014
|
8 |
4 |
p. 517-526
|
artikel
|
| 10 |
Favorable adverse event profile of sofosbuvir/ribavirin compared to boceprevir/interferon/ribavirin for treatment of hepatitis C
|
Narayanan, Shivakumar
|
|
|
8 |
4 |
p. 560-566
|
artikel
|
| 11 |
Favorable adverse event profile of sofosbuvir/ribavirin compared to boceprevir/interferon/ribavirin for treatment of hepatitis C
|
Narayanan, Shivakumar
|
|
2014
|
8 |
4 |
p. 560-566
|
artikel
|
| 12 |
Hepatitis B virus genotype B and mutations in basal core promoter and pre-core/core genes associated with acute-on-chronic liver failure: a multicenter cross-sectional study in China
|
Yang, Guifeng
|
|
2014
|
8 |
4 |
p. 508-516
|
artikel
|
| 13 |
Interobserver reproducibility of the controlled attenuation parameter (CAP) for quantifying liver steatosis
|
Ferraioli, Giovanna
|
|
2014
|
8 |
4 |
p. 576-581
|
artikel
|
| 14 |
Meta-analysis of patients with hepatitis C virus genotype 6: 48 weeks with pegylated interferon and ribavirin is superior to 24 weeks
|
Nguyen, Nghia H.
|
|
2014
|
8 |
4 |
p. 540-549
|
artikel
|
| 15 |
Real-life practice of antiviral therapy and disease patterns of patients with chronic hepatitis B: a single-center retrospective observation study
|
Jie, Yusheng
|
|
2014
|
8 |
4 |
p. 501-507
|
artikel
|
| 16 |
Soluble FGL2, a novel effector molecule of activated hepatic stellate cells, regulates T-cell function in cirrhotic patients with hepatocellular carcinoma
|
Sun, Ying
|
|
2014
|
8 |
4 |
p. 567-575
|
artikel
|
| 17 |
The burden of extended-spectrum β-lactamase-producing Enterobacteriaceae in patients with cirrhosis
|
Moreau, Richard
|
|
2014
|
8 |
4 |
p. 475-477
|
artikel
|
| 18 |
The natural history of HCV-related cirrhosis and its temporal progression across the different clinical stages
|
Gomez, Eduardo Vilar
|
|
2014
|
8 |
4 |
p. 527-539
|
artikel
|
Tijdschrift beschrijving